Table of Contents Author Guidelines Submit a Manuscript
Journal of Drug Delivery
Volume 2011, Article ID 476137, 13 pages
http://dx.doi.org/10.1155/2011/476137
Research Article

In Vitro Gene Delivery Mediated by Asialofetuin-Appended Cationic Liposomes Associated with γ-Cyclodextrin into Hepatocytes

1Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Kumamoto 862-0973, Japan
2School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo 192-0392, Japan
3Faculty of Pharmaceutical Sciences, Sojo University, 4-22-1 Ikeda, Kumamoto 860-0082, Japan

Received 1 July 2010; Accepted 10 October 2010

Academic Editor: Ali Nokhodchi

Copyright © 2011 Keiichi Motoyama et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. E. Raper and J. M. Wilson, “Gene therapy for human liver disease,” Progress in Liver Diseases, vol. 13, pp. 201–230, 1995. View at Google Scholar · View at Scopus
  2. P. L. Felgner, T. R. Gadek, M. Holm et al., “Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure,” Proceedings of the National Academy of Sciences of the United States of America, vol. 84, no. 21, pp. 7413–7417, 1987. View at Google Scholar · View at Scopus
  3. R. M. Abra, C. A. Hunt, and D. T. Lau, “Liposome disposition in vivo VI: delivery to the lung,” Journal of Pharmaceutical Sciences, vol. 73, no. 2, pp. 203–206, 1984. View at Google Scholar · View at Scopus
  4. T. M. Allen and J. M. Everest, “Effect of liposome size and drug release properties on pharmacokinetics of encapsulated drug in rats,” Journal of Pharmacology and Experimental Therapeutics, vol. 226, no. 2, pp. 539–544, 1983. View at Google Scholar · View at Scopus
  5. R. J. Mannino, E. S. Allebach, and W. A. Strohl, “Encapsulation of high molecular weight DNA in large unilamellar phospholipid vesicles. Dependence on the size of the DNA,” FEBS Letters, vol. 101, no. 2, pp. 229–232, 1979. View at Publisher · View at Google Scholar · View at Scopus
  6. N. Garcon, G. Gregoriadis, M. Taylor, and J. Summerfield, “Mannose-mediated targeted immunoadjuvant action of liposomes,” Immunology, vol. 64, no. 4, pp. 743–745, 1988. View at Google Scholar · View at Scopus
  7. Y. Kamimoto, D. Tanabe, S. Tashiro, T. Hiraoka, and Y. Miyauchi, “Changes in receptor-mediated endocytosis in liver sinusoidal cells after partial hepatectomy in the rat,” Liver, vol. 14, no. 3, pp. 141–147, 1994. View at Google Scholar · View at Scopus
  8. L. Roseng, H. Tolleshaug, and T. Berg, “Uptake, intracellular transport, and degradation of polyethylene glycol- modified asialofetuin in hepatocytes,” The Journal of Biological Chemistry, vol. 267, no. 32, pp. 22987–22993, 1992. View at Google Scholar · View at Scopus
  9. S. Becker, M. Spiess, and H.-D. Klenk, “The asialoglycoprotein receptor is a potential liver-specific receptor for Marburg virus,” Journal of General Virology, vol. 76, no. 2, pp. 393–399, 1995. View at Google Scholar · View at Scopus
  10. A. G. Y. Chang and G. Y. Wu, “Gene therapy: applications to the treatment of gastrointestinal and liver diseases,” Gastroenterology, vol. 106, no. 4, pp. 1076–1084, 1994. View at Google Scholar · View at Scopus
  11. T. Hara, H. Ishihara, Y. Aramaki, and S. Tsuchiya, “Specific uptake of asialofetuin-labeled liposomes by isolated hepatocytes,” International Journal of Pharmaceutics, vol. 42, no. 1-3, pp. 69–75, 1988. View at Google Scholar · View at Scopus
  12. T. Hara, H. Kuwasawa, Y. Aramaki et al., “Effects of fusogenic and DNA-binding amphiphilic compounds on the receptor-mediated gene transfer into hepatic cells by asialofetuin-labeled liposomes,” Biochimica et Biophysica Acta, vol. 1278, no. 1, pp. 51–58, 1996. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Abdou, J. Collomb, F. Sallas, A. Marsura, and C. Finance, “Beta-cyclodextrin derivatives as carriers to enhance the antiviral activity of an antisense oligonucleotide directed toward a coronavirus intergenic consensus sequence,” Archives of Virology, vol. 142, no. 8, pp. 1585–1602, 1997. View at Publisher · View at Google Scholar · View at Scopus
  14. M. A. Croyle, B. J. Roessler, C.-P. Hsu, R. Sun, and G. L. Amidon, “Beta cyclodextrins enhance adenoviral-mediated gene delivery to the intestine,” Pharmaceutical Research, vol. 15, no. 9, pp. 1348–1355, 1998. View at Publisher · View at Google Scholar · View at Scopus
  15. M. E. Davis and M. E. Brewster, “Cyclodextrin-based pharmaceutics: past, present and future,” Nature Reviews Drug Discovery, vol. 3, no. 12, pp. 1023–1035, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. B. J. Roessler, A. U. Bielinska, K. Janczak, I. Lee, and J. R. Baker Jr., “Substituted β-cyclodextrins interact with PAMAM dendrimer-DNA complexes and modify transfection efficiency,” Biochemical and Biophysical Research Communications, vol. 283, no. 1, pp. 124–129, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. K. Uekama, F. Hirayama, and T. Irie, “Cyclodextrin drug carrier systems,” Chemical Reviews, vol. 98, no. 5, pp. 2045–2076, 1998. View at Google Scholar · View at Scopus
  18. N. C. Bellocq, S. H. Pun, G. S. Jensen, and M. E. Davis, “Transferrin-containing, cyclodextrin polymer-based particles for tumor-targeted gene delivery,” Bioconjugate Chemistry, vol. 14, no. 6, pp. 1122–1132, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. S. H. Pun, N. C. Bellocq, A. Liu et al., “Cyclodextrin-modified polyethylenimine polymers for gene delivery,” Bioconjugate Chemistry, vol. 15, no. 4, pp. 831–840, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. H. Arima, F. Kihara, F. Hirayama, and K. Uekama, “Enhancement of gene expression by polyamidoamine dendrimer conjugates with α-, β-, and γ-cyclodextrins,” Bioconjugate Chemistry, vol. 12, no. 4, pp. 476–484, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Arima, S. Yamashita, Y. Mori et al., “In vitro and in vivo gene delivery mediated by lactosylated dendrimer/α-cyclodextrin conjugates (G2) into hepatocytes,” Journal of Controlled Release, vol. 146, no. 1, pp. 106–117, 2010. View at Google Scholar
  22. C. Lawrencia, R. Mahendran, and K. Esuvaranathan, “Transfection of urothelial cells using methyl-β-cyclodextrin solubilized cholesterol and Dotap,” Gene Therapy, vol. 8, no. 10, pp. 760–768, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. H. Arima, Y. Hagiwara, F. Hirayama, and K. Uekama, “Enhancement of antitumor effect of doxorubicin by its complexation with γ-cyclodextrin in pegylated liposomes,” Journal of Drug Targeting, vol. 14, no. 4, pp. 225–232, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. G. R. Bartlett, “Phosphorus assay in column chromatography,” The Journal of Biological Chemistry, vol. 234, no. 3, pp. 466–468, 1959. View at Google Scholar
  25. M. M. Bradford, “A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding,” Analytical Biochemistry, vol. 72, no. 1-2, pp. 248–254, 1976. View at Google Scholar · View at Scopus
  26. L. H. Koehler, “Differentiation of carbohydrates by anthrone reaction rate and color intensity,” Analytical Chemistry, vol. 24, no. 10, pp. 1576–1579, 1952. View at Google Scholar · View at Scopus
  27. T. Tsutsumi, F. Hirayama, K. Uekama, and H. Arima, “Evaluation of polyamidoamine dendrimer/α-cyclodextrin conjugate (generation 3, G3) as a novel carrier for small interfering RNA (siRNA),” Journal of Controlled Release, vol. 119, no. 3, pp. 349–359, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. K. Motoyama, H. Arima, H. Toyodome, T. Irie, F. Hirayama, and K. Uekama, “Effect of 2,6-di-O-methyl-α-cyclodextrin on hemolysis and morphological change in rabbit's red blood cells,” European Journal of Pharmaceutical Sciences, vol. 29, no. 2, pp. 111–119, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. K. Motoyama, H. Toyodome, R. Onodera et al., “Involvement of lipid rafts of rabbit red blood cells in morphological changes induced by methylated β-cyclodextrins,” Biological and Pharmaceutical Bulletin, vol. 32, no. 4, pp. 700–705, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. Y. Ohtani, T. Irie, K. Uekama, K. Fukunaga, and J. Pitha, “Differential effects of α-, β- and γ-cyclodextrins on human erythrocytes,” European Journal of Biochemistry, vol. 186, no. 1-2, pp. 17–22, 1989. View at Publisher · View at Google Scholar · View at Scopus
  31. K. Miyajima, K. Tomita, and M. Nakagaki, “Complex formation between Di- and Monophosphatidylcholines and cyclodextrin in water,” Chemical and Pharmaceutical Bulletin, vol. 33, pp. 2587–2590, 1985. View at Google Scholar
  32. J. Nishijo and H. Mizuno, “Interactions of cyclodextrins with DPPC liposomes. Differential scanning calorimetry studies,” Chemical and Pharmaceutical Bulletin, vol. 46, no. 1, pp. 120–124, 1998. View at Google Scholar · View at Scopus
  33. J. Bischoff, S. Libresco, M. A. Shia, and H. F. Lodish, “The H1 and H2 polypeptides associate to form the asialoglycoprotein receptor in human hepatoma cells,” Journal of Cell Biology, vol. 106, no. 4, pp. 1067–1074, 1988. View at Google Scholar · View at Scopus
  34. D.-J. Peng, J. Sun, Y.-Z. Wang et al., “Inhibition of hepatocarcinoma by systemic delivery of Apoptin gene via the hepatic asialoglycoprotein receptor,” Cancer Gene Therapy, vol. 14, no. 1, pp. 66–73, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  35. K. Wada, H. Arima, T. Tsutsumi, F. Hirayama, and K. Uekama, “Enhancing effects of galactosylated dendrimer/α-cyclodextrin conjugates on gene transfer efficiency,” Biological and Pharmaceutical Bulletin, vol. 28, no. 3, pp. 500–505, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. P. L. Katsel and R. J. Greenstein, “Eukaryotic gene transfer with liposomes: effect of differences in lipid structure,” Biotechnology Annual Review, vol. 5, pp. 197–220, 2000. View at Publisher · View at Google Scholar · View at Scopus
  37. B. Ruozi, F. Forni, R. Battini, and M. A. Vandelli, “Cationic liposomes for gene transfection,” Journal of Drug Targeting, vol. 11, no. 7, pp. 407–414, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. H. Farhood, N. Serbina, and L. Huang, “The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer,” Biochimica et Biophysica Acta, vol. 1235, no. 2, pp. 289–295, 1995. View at Publisher · View at Google Scholar · View at Scopus
  39. S. W. Hui, M. Langner, Y.-L. Zhao, P. Ross, E. Hurley, and K. Chan, “The role of helper lipids in cationic liposome-mediated gene transfer,” Biophysical Journal, vol. 71, no. 2, pp. 590–599, 1996. View at Google Scholar · View at Scopus
  40. A. Natsume, M. Mizuno, Y. Ryuke, and J. Yoshida, “Antitumor effect and cellular immunity activation by murine interferon-β gene transfer against intracerebral glioma in mouse,” Gene Therapy, vol. 6, no. 9, pp. 1626–1633, 1999. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  41. Y. Aramaki, A. Inaba, and S. Tsuchiya, “Selective incorporation of asialofetuin into hepatocyte of rat,” Biopharmaceutics and Drug Disposition, vol. 6, no. 4, pp. 389–400, 1985. View at Google Scholar · View at Scopus